Copper64DOTATATEQualityChecker
Copper-64 DOTATATE
Utility description: Copper-64 DOTATATE
Copper-64 DOTATATE Quality Checker — Copper-64 DOTATATE for PET Imaging of Neuroendocrine Tumors
ℹ️ Utility checks critical parameters of [64Cu]Cu-DOTATATE:
• Radionuclidic purity (≥99.9%)
• Radiochemical purity (≥95%)
• Free Copper-64 impurity (≤2.0%)
• DOTATATE Ligand impurity (≤5.0%)
• Specific activity (≥20 GBq/μmol)
• pH, endotoxins, sterility, heavy metals
⚠️ CRITICAL: Free Copper-64 >2.0% → high liver background, masking metastases!
Specific activity <20 GBq/μmol → saturation of somatostatin receptors (SSTR2) by "cold" drug, reduced sensitivity!
Usage:
Copper64DOTATATEQualityChecker.exe → demo mode (console output)
Copper64DOTATATEQualityChecker.exe input.csv output.json → evaluate your data
Input format:
BatchNumber,RadionuclidicPurityPercent,RadiochemicalPurityPercent,FreeCopperPercent,DOTATATELigandImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,SpecificActivityGBqPerUmol
Example (sterility: 0=sterile, 1=contaminated):
CU64-DOTA-2026-001,99.98,98.2,0.8,1.0,7.0,40.0,0,3,35.0
— WHY IS THIS NEEDED?
[64Cu]Cu-DOTATATE is a somatostatin analog peptide radiopharmaceutical labeled with Copper-64:
• Cu-64 Half-life: 12.7 hours — allows scanning 24 hours post-injection (delayed imaging)
• Mechanism: High-affinity binding to Somatostatin Receptor type 2 (SSTR2) expressed on Neuroendocrine Tumors (NETs)
• Advantage over Ga-68: Longer half-life allows centralized production and distribution, and improved contrast due to background clearance
⚠️ CRITICAL:
• Radiochemical purity ≥95% — ensures specific tumor uptake
• Free Copper ≤2.0% — free Cu-64 is taken up by the liver. Since the liver is a common site for NET metastases, high background can mask lesions (false negatives).
• Specific activity ≥20 GBq/μmol — necessary to minimize peptide mass, avoiding pharmacological effects and receptor saturation
• pH 4.5–8.5 — physiological range
• Endotoxins ≤175 EU/vial — safety standard
• Sterility — MANDATORY
Key features:
• Strict control of free copper due to risk of false negatives in liver imaging
• Higher specific activity requirements compared to small molecule diagnostics
• Radionuclidic purity check
Critical parameters:
• Radionuclidic purity: ≥99.9%
• Radiochemical purity: ≥95.0%
• Free Copper-64: ≤2.0%
• DOTATATE Ligand: ≤5.0%
• Specific activity: ≥20.0 GBq/μmol
• pH: 4.5–8.5
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm
💡 Usage tips:
1. Radiochemical purity determined by HPLC or TLC
2. TLC with silica gel and eluent (e.g., 0.1 M sodium citrate pH 5.0 or acetonitrile/water mixture) is used to separate free Cu-64 from the complex
3. Specific activity calculated from activity to peptide molar amount ratio (determined by HPLC-UV)
4. Due to potential transchelation of copper in vivo, complex stability is critical. Control of ligand impurities is important.
⚠️ Note: Unlike Ga-68 DOTATATE, the Cu-64 complex is more lipophilic and may have a different biodistribution profile. Quality control must be particularly strict regarding free copper, as copper metabolism differs from gallium.input.csv
BatchNumber,RadionuclidicPurityPercent,RadiochemicalPurityPercent,FreeCopperPercent,DOTATATELigandImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,SpecificActivityGBqPerUmol CU64-DOTA-2026-001,99.98,98.2,0.8,1.0,7.0,40.0,0,3,35.0
URS & FS — User Requirements and Functional Specification
This document describes the controlled interface and behaviour of Copper64DOTATATEQualityChecker for Copper-64 DOTATATE.
Domain limits and critical parameters
- ℹ️ Utility checks critical parameters of [64Cu]Cu-DOTATATE:
- • Radionuclidic purity (≥99.9%)
- • Radiochemical purity (≥95%)
- • Free Copper-64 impurity (≤2.0%)
- • DOTATATE Ligand impurity (≤5.0%)
- • Specific activity (≥20 GBq/μmol)
- • pH, endotoxins, sterility, heavy metals
- ⚠️ CRITICAL: Free Copper-64 >2.0% → high liver background, masking metastases!
- BatchNumber,RadionuclidicPurityPercent,RadiochemicalPurityPercent,FreeCopperPercent,DOTATATELigandImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,SpecificActivityGBqPerUmol
- Example (sterility: 0=sterile, 1=contaminated):
- ⚠️ CRITICAL:
- • Radiochemical purity ≥95% — ensures specific tumor uptake
- • Free Copper ≤2.0% — free Cu-64 is taken up by the liver. Since the liver is a common site for NET metastases, high background can mask lesions (false negatives).
- • Specific activity ≥20 GBq/μmol — necessary to minimize peptide mass, avoiding pharmacological effects and receptor saturation
URS — User Requirements Specification
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The utility shall accept an input.csv file with the exact headers defined in the data contract. | High | The file is processed without manual header editing. |
| URS-002 | The utility shall perform deterministic QC evaluation for Copper-64 DOTATATE using input values, approved limits and domain rules. | High | Each input row receives a PASS / WARNING / FAIL status. |
| URS-003 | The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility. | High | Schema and conversion errors are explicitly reported. |
| URS-004 | The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present. | High | A critical deviation causes FAIL or a separate critical finding. |
| URS-005 | The utility shall generate output.json with machine-readable results, source values, warnings and failures. | High | JSON is suitable for LIMS/ELN/MES integration and QA/QC review. |
| URS-006 | The utility shall not use machine learning to decide conformance. | Medium | The result is based on explicit rules, thresholds and input values. |
| URS-007 | The utility shall preserve traceability between batch number, input values, applied rules and final status. | High | The output contains the batch identifier and the list of checked parameters. |
| URS-008 | The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators. | Medium | URS & FS, input.csv/output.json contract and test scenarios are supplied with the utility. |
input.csv contract
| # | Field | Type | Sample | Purpose |
|---|---|---|---|---|
| 1 | BatchNumber | string | CU64-DOTA-2026-001 | Batch or lot identifier used for traceability. |
| 2 | RadionuclidicPurityPercent | string | 99.98 | Radionuclidic purity; a critical radiation-safety and impurity parameter. |
| 3 | RadiochemicalPurityPercent | string | 98.2 | Radiochemical purity; confirms the labelled chemical form and binding quality. |
| 4 | FreeCopperPercent | decimal | 0.8 | Free radionuclide / unbound species; important for non-target uptake and toxicity. |
| 5 | DOTATATELigandImpurityPercent | string | 1.0 | Controlled impurity or residual material. |
| 6 | pH | decimal | 7.0 | Solution pH; relevant for stability, compatibility and administration. |
| 7 | EndotoxinsEU | decimal | 40.0 | Bacterial endotoxins; critical for parenteral administration. |
| 8 | SterilityTest | flag / boolean | 0 | Sterility result; critical release parameter. |
| 9 | HeavyMetalsPPM | decimal | 3 | Elemental impurity / metal residue parameter. |
| 10 | SpecificActivityGBqPerUmol | decimal | 35.0 | Radioactivity value used for release, decay or dose-related assessment. |
BatchNumber,RadionuclidicPurityPercent,RadiochemicalPurityPercent,FreeCopperPercent,DOTATATELigandImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,SpecificActivityGBqPerUmol CU64-DOTA-2026-001,99.98,98.2,0.8,1.0,7.0,40.0,0,3,35.0
FS — Functional Specification
| ID | Function | Implementation |
|---|---|---|
| FS-001 | CSV import | Read input.csv in UTF-8/CSV-compatible format and validate the header and expected columns. |
| FS-002 | Schema validation | Check mandatory fields and column count; report unknown or missing key fields. |
| FS-003 | Type conversion | Convert numeric, flag and text values; invalid formats are recorded as row-level errors. |
| FS-004 | Domain rule engine | Apply domain rules for Copper-64 DOTATATE, including critical limits from the utility description and approved specification. |
| FS-005 | Status aggregation | Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance. |
| FS-006 | JSON export | Write output.json with detailed checks, source values, warnings, failures and critical findings. |
| FS-007 | Audit support | Keep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation. |
| FS-008 | Integration contract | Support the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation. |
Example output.json
{
"utilityId": "copper64-dotatate-quality-checker",
"api": "Copper-64 DOTATATE",
"overallStatus": "PASS|WARNING|FAIL",
"sourceFile": "input.csv",
"checks": [
{
"parameter": "BatchNumber",
"value": "CU64-DOTA-2026-001",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadionuclidicPurityPercent",
"value": "99.98",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadiochemicalPurityPercent",
"value": "98.2",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "FreeCopperPercent",
"value": "0.8",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "DOTATATELigandImpurityPercent",
"value": "1.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "pH",
"value": "7.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "EndotoxinsEU",
"value": "40.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "SterilityTest",
"value": "0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": []
}
OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| OQ-001 | Valid sample row | PASS or acceptable WARNING according to the rules. |
| OQ-002 | Mandatory column missing | Schema error or FAIL. |
| OQ-003 | Non-numeric value in numeric field | Type-conversion error. |
| OQ-004 | Critical parameter outside limit | FAIL and critical finding. |
| PQ-001 | User real batch/lot | Reviewed result with input.csv and output.json retained. |
QA/QC and change control
- Do not rename columns without updating the validator and test set.
- Retain
input.csv,output.json, executable version and checksum. - Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
- Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.
Included in packages
Endocrinology QC Suite
QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.
OpenNeurology QC Suite
QC package for neurology and neuropsychiatry: antiepileptics, antiparkinsonian medicines, antidepressants, antipsychotics, analgesics and neurological diagnostic radiopharmaceuticals.
OpenPetRad3: expanded PET/SPECT and radiopharmaceutical QC package
A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.
OpenRadiology QC Suite
QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.
OpenRPH isotope family: Ga/Ge
Ga-67, Ga-68 and Ge-68: generator, radiolabelling, PET/SPECT and purity workflows.
OpenRPH isotope family: long-lived PET / immuno-PET
Cu-64, Zr-89, I-124, Mn-52 and Y-86 for antibodies, slow kinetics and extended imaging.
OpenRPH organ/system: brain and CNS
Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.
OpenRPH organ/system: endocrine, thyroid and NET
Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.
OpenRPH organ/system: hepatobiliary and GI
HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.
OpenRPH organ/system: oncology and theranostics
Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.
OpenRPH use case: PET/SPECT oncology diagnostics and receptor imaging
F-18, Ga-68, Cu-64, Zr-89, In-111 and other diagnostic tracers: synthesis, purity, receptor targeting, immuno-PET and generator-based workflows.
OpenRPH workflow: generators and isotope purity
Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.
OpenRPH workflow: imaging QC and quantitative interpretation
Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.
OpenRPH workflow: product release QC
Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.
OpenRPH workflow: stability, storage, decay and waste
Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.
OpenRPH workflow: synthesis, labelling and kit reconstitution
Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.
OpenRPH: combined radiopharmaceutical QC package
RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.
Open